KIT and acute myeloid leukemia: With the enlargement and improvement of comprehensive sequencing spectrum and coverage in modern NGS platforms, more growing genetic lesions of potentially clinical relevance on varying loci within the KIT gene would be identified, as well as more coexisting genomic lesions, thereby giving profound insight into AML classification and informing prognostic stratification.45